Abstract:Sotalol is a class III antiarrhythmic drug with beta-adrenergic blocking activity, used to manage both supraventricular and ventricular arrhythmias. It is available in both oral and intravenous formulations. 1 The Food and Drug Administration approved intravenous Sotalol in March 2020. Sotalol is known to cause corrected QT interval (QTc) prolongation with serum sotalol concentration linearly correlating with QTc length regardless of the route of administration, 2,3 with women being at higher risk than men. 4 … Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.